STIMULAN(R) certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics STIMULAN(R) certified to resolve infection and reduce the need for secondary surgery STIMULAN(R) is ...

Multidrug-resistant gram-negative infections (MDRGNIs) are an emerging and deadly threat worldwide. Some of these infections are now resistant to nearly all antibiotics, and very few treatment options ...

Please provide your email address to receive an email when new articles are posted on . Gram-negative bacteria comprise most of the CDC and WHO’s lists of critical and urgent antibiotic-resistant ...

Please provide your email address to receive an email when new articles are posted on . Ninety-day risk of all-cause mortality was 11.2% and 9.9% for patients given a shorter or longer antibiotic ...

FPI-2119 offers potential solution to multi-drug-resistant Gram-negative infections. EDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader i ...

Urinary tract infections (UTIs) are common, but increasingly hard to treat because the bacteria that cause them are developing resistance to many antibiotics. Researchers headed by a team at the ...

ORLANDO, FL, UNITED STATES, January 27, 2026 /EINPresswire.com/ -- Orakle LLC is pleased to announce the launch of a ...

Scientists at Duke University report they have developed a synthetic antibiotic that could be effective against drug-resistant superbugs and bacteria such as Salmonella, Pseudomonas, and E. coli.

Hospital uptake of newer antibiotics to treat multidrug-resistant gram-negative bacteria was low over a 5-year period, according to a retrospective cohort study. Fully 41.5% of episodes of ...

Since the 1960s, there has been a decline in the discovery of new antibiotics, particularly against Gram-negative bacteria. Increases in antibiotic resistance call for an urgent need to identify ...